AMYLIN PHARMACEUTICALS INC: common_shares_outstanding
| Value | {"unit": "shares", "value": 146289, "concept": "us-gaap:CommonStockSharesOutstanding"} |
|---|---|
| Period | (as of 2011-12-31) |
| Status | current |
| Entity | AMYLIN PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:48:02.716993+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/394bb934-a571-47c4-9276-eec0dc0d645a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000881464-12-000006 · Open the official SEC filing →Retrieved: 2026-08-19T08:48:02.716993+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000881464/common-shares-outstanding/2011-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/394bb934-a571-47c4-9276-eec0dc0d645a
History
- supersedes {"unit": "shares", "value": 146289000, "concept": "us-gaap:CommonStockSharesOutstanding"} (evidence 0001193125-12-072788)